Eun Seok Kang Selected Research

Pioglitazone (Actos)

10/2022	The effects of the voglibose on non-alcoholic fatty liver disease in mice model.
1/2022	Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study.
10/2020	Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis.
1/2020	Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial.
2/2019	Differential Effects of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors on Insulin Resistance and β-Cell Function in Type 2 Diabetes Mellitus: A Propensity Score-Matched Analysis.
1/2019	Low-dose pioglitazone can ameliorate learning and memory impairment in a mouse model of dementia by increasing LRP1 expression in the hippocampus.
1/2018	Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus.
2/2016	Rosiglitazone Use and the Risk of Bladder Cancer in Patients With Type 2 Diabetes.
10/2012	The risk of bladder cancer in korean diabetic subjects treated with pioglitazone.
2/2012	The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eun Seok Kang Research Topics

Disease

81	Type 2 Diabetes Mellitus (MODY) 04/2024 - 12/2004
41	Insulin Resistance 01/2023 - 02/2005
17	Body Weight (Weight, Body) 01/2022 - 05/2006
13	Diabetes Mellitus 01/2024 - 03/2007
13	Non-alcoholic Fatty Liver Disease 10/2022 - 10/2011
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 12/2004
11	Atherosclerosis 01/2020 - 05/2008
10	Obesity 01/2022 - 12/2011
10	Fibrosis (Cirrhosis) 01/2022 - 10/2011
8	Albuminuria 08/2020 - 01/2008
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018 - 08/2005
7	Hyperglycemia 01/2023 - 01/2014
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 04/2024 - 01/2011
6	Neoplasms (Cancer) 01/2022 - 10/2012
6	Inflammation (Inflammations) 11/2020 - 10/2011
6	Hypertension (High Blood Pressure) 01/2020 - 02/2014
6	Weight Loss (Weight Reduction) 01/2019 - 01/2013
6	Dyslipidemias (Dyslipidemia) 06/2017 - 12/2012
5	Dementia (Dementias) 01/2022 - 02/2012
5	Fatty Liver 01/2022 - 01/2012
5	Hepatocellular Carcinoma (Hepatoma) 05/2019 - 01/2017
5	Diabetes Complications 01/2018 - 09/2010
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2016 - 08/2005
4	Weight Gain 01/2020 - 06/2006
4	Prediabetic State (Prediabetes) 01/2020 - 01/2014
4	Hypercholesterolemia 05/2019 - 02/2014
4	Hypercalcemia (Milk Alkali Syndrome) 03/2018 - 04/2005
4	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2007 - 02/2006
4	Parkinson Disease (Parkinson's Disease) 02/2007 - 02/2006
4	Neuroblastoma 02/2007 - 02/2006
3	Liver Diseases (Liver Disease) 01/2024 - 01/2017
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 02/2012
3	Proteinuria 08/2020 - 01/2019
3	Carotid Artery Diseases 01/2020 - 02/2008
3	Coronary Disease (Coronary Heart Disease) 06/2008 - 12/2004
2	Sarcopenia 01/2024 - 10/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2018
2	Hypertrophy 11/2021 - 05/2007
2	Chronic Kidney Failure (Chronic Renal Failure) 03/2020 - 08/2016
2	Disease Progression 01/2020 - 10/2011
2	Heart Failure 01/2020 - 01/2018
2	Chronic Renal Insufficiency 01/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

40	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 02/2005
30	Insulin (Novolin)FDA Link 04/2024 - 02/2005
15	Rosiglitazone (Avandia)FDA Link 02/2016 - 05/2005
13	AdiponectinIBA 01/2017 - 05/2005
12	Metformin (Glucophage)FDA LinkGeneric 01/2023 - 02/2007
12	Pioglitazone (Actos)FDA Link 10/2022 - 03/2010
12	AlbuminsIBA 08/2020 - 12/2012
11	Triglycerides (Triacylglycerol)IBA 01/2023 - 05/2007
11	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 02/2014
10	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 01/2006
10	LipidsIBA 01/2019 - 02/2006
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2007
8	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2023 - 07/2012
8	Dipeptidyl-Peptidase IV InhibitorsIBA 06/2022 - 06/2014
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
7	CreatinineIBA 11/2021 - 05/2013
6	Blood Glucose (Blood Sugar)IBA 04/2024 - 01/2008
5	Sodium-Glucose Transporter 2 InhibitorsIBA 06/2022 - 06/2017
5	CholesterolIBA 01/2020 - 10/2006
5	Immunosuppressive Agents (Immunosuppressants)IBA 10/2016 - 01/2008
5	C-PeptideIBA 07/2016 - 02/2006
5	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2008 - 02/2006
4	LDL CholesterolIBA 01/2023 - 10/2006
4	SodiumIBA 06/2022 - 06/2017
4	glimepiride (Amarel)FDA LinkGeneric 01/2022 - 02/2007
4	Hexosaminidases (Hexosaminidase)IBA 01/2022 - 07/2016
4	AdipokinesIBA 10/2019 - 02/2007
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 06/2014
4	CalciumIBA 03/2018 - 06/2007
4	2,4-thiazolidinedione (thiazolidinedione)IBA 01/2018 - 02/2012
4	Choline (Choline Chloride)IBA 10/2017 - 10/2011
4	Methionine (L-Methionine)FDA Link 10/2017 - 10/2011
4	C-Reactive ProteinIBA 03/2016 - 12/2004
4	LeptinIBA 01/2012 - 07/2008
4	NeurotoxinsIBA 02/2007 - 02/2006
3	LC15-0444IBA 01/2023 - 12/2019
3	dapagliflozinIBA 01/2023 - 01/2018
3	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 06/2014
3	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 05/2007
3	Ezetimibe (Zetia)FDA Link 01/2022 - 10/2017
3	ipragliflozinIBA 11/2021 - 01/2019
3	LinagliptinIBA 01/2021 - 08/2016
3	ThiazolidinedionesIBA 02/2019 - 02/2012
3	SymportersIBA 01/2019 - 06/2017
3	HDL CholesterolIBA 05/2013 - 10/2006
3	lithospermate BIBA 09/2010 - 05/2008
2	Sodium-Glucose Transport ProteinsIBA 01/2023 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2020 - 12/2010
2	EnzymesIBA 11/2020 - 04/2016
2	isonitrosoacetophenoneIBA 08/2020 - 01/2019
2	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2020 - 01/2019
2	InterleukinsIBA 01/2020 - 12/2007
2	Hormones (Hormone)IBA 01/2020 - 11/2016
2	InflammasomesIBA 01/2020 - 10/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 08/2005

Therapy/Procedure

19	Therapeutics 04/2024 - 10/2011
11	Glycemic Control 01/2022 - 08/2006
3	Transplantation 01/2024 - 03/2007